Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aeterna Zentaris (NQ: AEZS )

0.8711 USD +0.0395 (+4.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,907,685
Open 0.8500
Bid (Size) 0.8711 (4)
Ask (Size) 0.8749 (10)
Prev. Close 0.8316
Today's Range 0.8326 - 0.8978
52wk Range 0.2900 - 3.620
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aeterna Zentaris Commences Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
From GlobeNewswire News Releases
Aeterna Zentaris to Present at the Q2 Virtual Investor Summit
From GlobeNewswire News Releases

Performance

YTD
+69.18%
+69.18%
1 Month
-4.27%
-4.27%
3 Month
-51.87%
-51.87%
6 Month
+148.89%
+148.89%
1 Year
-6.33%
-6.33%

More News

Read More
Aeterna Zentaris Announces the Selection of a Development Candidate in the DC-PTH Program for the Potential Treatment of Primary Hypoparathyroidism
From GlobeNewswire News Releases
Aeterna Zentaris Announces Results of 2021 Annual Meeting of Shareholders
From GlobeNewswire News Releases
Aeterna Zentaris Reports First Quarter 2021 Financial Results and Provides Pipeline Program Updates
From GlobeNewswire News Releases
Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer
From GlobeNewswire News Releases
Aeterna Zentaris Announces Virtual 2021 Annual Meeting of Shareholders
From GlobeNewswire News Releases
3 Penny Stocks to Watch During the Last Week of April
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Aeterna Zentaris Reports Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
Aeterna Zentaris Starts Research Study On How Well Macimorelin Works For Growth Hormone Deficiency Diagnosis
Tags News General Benzinga
From Benzinga
Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.